 | Up a level |
2018
Pal, Sumanta K., Rosenberg, Jonathan E., Hoffman-Censits, Jean H., Berger, Raanan, Quinn, David I., Galsky, Matthew D., Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, Jan H. M., Gravis, Gwenaelle, Medioni, Jacques, Maroto, Pablo, Sriuranpong, Virote, Charoentum, Chaiyut, Burris, Howard A., Grunwald, Viktor, Petrylak, Daniel, Vaishampayan, Ulka 
ORCID: 0000-0001-5800-4571, Gez, Eliahu, De Giorgi, Ugo, Lee, Jae-Lyun, Voortman, Jens, Gupta, Sumati, Sharma, Sunil, Mortazavi, Amir, Vaughn, David J., Isaacs, Randi, Parker, Katie, Chen, Xueying, Yu, Kun, Porter, Dale, Porta, Diana Graus and Bajorin, Dean F.
(2018).
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
Cancer Discov., 8 (7).
S. 812 - 822.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 2159-8290
2016
Pal, Sumanta K., Rosenberg, Jonathan E., Keam, Bhumsuk, Wolf, Juergen, Berger, Raanan, Dittrich, Christian, Hoffman-Censits, Jean H., Quinn, David ORCID: 0000-0002-1411-0417, van der Noll, Ruud, Burris, Howard A., Galsky, Matt D., Gravis, Gwenaelle, Lee, Jae-Lyun, Medioni, Jacques, Mortazavi, Amir, Maroto, Pablo, Parker, Katie, Chen, Xueying, Isaacs, Randi and Bajorin, Dean F.
(2016).
Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations.
J. Clin. Oncol., 34 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2014
Miller, Kathy D., Dieras, Veronique, Harbeck, Nadia, Andre, Fabrice, Mahtani, Reshma L., Gianni, Luca, Albain, Kathy S., Crivellari, Diana, Fang, Liang, Michelson, Glenn, de Haas, Sanne L. and Burris, Howard A. (2014). Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast Cancer. J. Clin. Oncol., 32 (14). S. 1437 - 1446. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755